Doctor concerned with health care law

Breaking news and expert analysis on legal and compliance issues

[Back To Home][Back To Archives]

From Health Law Daily, January 2, 2018

Court dismisses AHA’s challenge to 340B cuts

By Bryant Storm, J.D.

The American Hospital Association (AHA) must exhaust administrative remedies prior to challenging HHS cuts to the 340B Program in court. A district court denied the AHA’s motion for a preliminary injunction to prevent HHS from reducing reimbursement for 340B drugs from average sales price (ASP) plus 6 percent to ASP minus 22.5 percent. The court did not rule on the merits of the case and instead held that, in the absence of a final decision from the HHS Secretary, the court lacked subject matter jurisdiction (American Hospital Association v. Hargan, December 29, 2017, Contreras, R.).

340B Program cuts. The 340B Program (see 42 U.S.C. §256b, as expanded by Secs. 2501, 7101, and 7102 of the Patient Protection and Affordable Care Act (ACA) (P.L. 111-148)), requires drug manufacturers to provide covered outpatient drugs at a discounted price to covered facilities. In 2017, CMS issued a Final rule (82 FR 52356) changing its reimbursement for separately payable drugs and biologics (other than pass-through drugs and vaccines) acquired through the 340B Program from ASP plus 6 percent to ASP minus 22.5 percent (see CMS cut to 340B spending overshadows OPPS update; associations threaten suit, November 2, 2017).

Complaint. The AHA filed suit challenging the cuts, asserting that the reduction in reimbursement would threaten hospitals’ ability to provide care to communities, including underserved patient populations. Specifically, the AHA sought a preliminary injunction preventing the 340B provisions of the rule from taking effect on January 1, 2018, alleging that member hospitals and the populations served "would suffer significant and immediate harm" which would be "flatly inconsistent" with the purpose of the 340B program (see AHA makes good on threats to sue over 340B cuts, November 14, 2017). The AHA asserted that the nearly 30 percent reduction in the Medicare reimbursement rate for 340B drugs exceeded the Secretary’s statutory authority under 42 U.S.C. § 1395l(t)(14)(A)(iii) and, therefore, violated the Administrative Procedure Act (APA).

Jurisdiction. The court held that the Medicare Act limits federal court jurisdiction on claims arising under the statute to circumstances where the Secretary has rendered a final decision on the matter. In other words, before a federal court would have jurisdiction to decide the 340B issue, a claim must be presented to the HHS Secretary and administrative remedies must be exhausted. The court noted that the AHA had "not yet presented any specific claim for reimbursement to the Secretary upon which the Secretary might make a final decision." The court rejected the AHA’s argument that by commenting on the Proposed rule, the presentment requirement was satisfied, noting that those comments did not constitute "concrete claims for reimbursement."

Commentary. In a press release following the decision, Rick Pollack, AHA’s president and CEO, said: "we are disappointed in this decision from the court and will continue our efforts in the courts and the Congress to reverse these significant cuts to the 340B program."

The case is No. 1:17-cv-02447-RC.

Attorneys: Carlos T. Angulo (Zuckerman Spaeder, LLP) for American Hospital Association. Nikhel Sus, U.S. Department of Justice, for Eric D. Hargan, Acting Secretary, U.S. Department of Health and Human Services.

Companies: American Hospital Association; U.S. Department of Health and Human Services

MainStory: TopStory CaseDecisions DistrictofColumbiaNews ReimbursementNews CMSNews BillingNews CharityNews DrugBiologicNews PartBNews OPPSNews PrescriptionDrugNews

Back to Top

Health Law Daily

Introducing Wolters Kluwer Health Law Daily — a daily reporting service created by attorneys, for attorneys — providing same-day coverage of breaking news, court decisions, legislation, and regulatory activity.

A complete daily report of the news that affects your world

  • View full summaries of federal and state court decisions.
  • Access full text of legislative and regulatory developments.
  • Customize your daily email by topic and/or jurisdiction.
  • Search archives for stories of interest.

Not just news — the right news

  • Get expert analysis written by subject matter specialists—created by attorneys for attorneys.
  • Track law firms and organizations in the headlines with our new “Who’s in the News” feature.
  • Promote your firm with our new reprint policy.

24/7 access for a 24/7 world

  • Forward information with special copyright permissions, encouraging collaboration between counsel and colleagues.
  • Save time with mobile apps for your BlackBerry, iPhone, iPad, Android, or Kindle.
  • Access all links from any mobile device without being prompted for user name and password.